Depression, Anxiety, and Stress: A Multi-Omics Approach with David Brady from the NANP 2023 HEALCon. Take this quiz to earn 1.5 CECs.

Dr. David M. Brady has over 30 years of experience as an integrative medicine practitioner and 25 years in health sciences academia. He is a licensed naturopathic medical physician in Connecticut and Vermont, is board-certified in functional medicine and clinical nutrition, and is a fellow of the American College of Nutrition. He is the Chief Medical Officer for Diagnostic Solutions Labs, LLC, and Designs for Health, Inc. He is in private practice in the integrative medicine group Whole Body Medicine in Fairfield, CT (USA). He is the former long-term vice president of the Division of Health Sciences and director of the Human Nutrition Institute at the University of Bridgeport in Connecticut. He continues to serve as director and professor emeritus of nutrition. He has appeared on the plenary speaking panel of some of the field’s largest and most prestigious conferences, including IFM, ACAM, A4M, ACN, IHS, AANP, AIHM, and many others. Dr. Brady has published many peer-reviewed scientific papers and textbooks on functional and naturopathic medicine, clinical nutrition, chronic pain, autoimmunity, and functional gastroenterology.

Presentation Description:
Please join the Chief Medical Officer of Diagnostic Solutions Laboratory and Designs for Health, Dr. David Brady, as he presents “Depression, Anxiety, and Stress: A Multi-Omics Approach.” Depression, anxiety, and stress-related conditions impact almost 40 million Americans each year.1 With so many patients suffering, practitioners need tools to help assess and determine therapeutic approaches to common mental health conditions. In this exciting presentation, Dr. Brady will teach practitioners to use a multi-omics approach to optimize outcomes for patients suffering from stress, depression, and anxiety.
1-Anxiety & Depression Association of America Facts and Statistics. (2021, September 19). Anxiety & Depression Association of America. Retrieved March 30, 2022, from https://adaa.org/understanding-anxiety/facts-statistics

Learning Objectives:

• Explore the gut-brain connection and how the gut microbiota impacts mental health conditions
• Identify critical associations between metabolomic markers and clinical symptoms related to mental health disorders
• Determine key single nucleotide polymorphisms (SNPs) that are prevalent in patients suffering from depression and anxiety
• Apply the multi-omics approach in clinical practice using the microbiomics, organic metabolomics, and nutrigenomics to identify the most efficacious opportunities for intervention, and the most appropriate therapeutic agents to use.